Association of HIF-1A (rs11549465) gene polymorphism with congenital malformations and intrauterine growth retardation of the fetus

Cover Page

Cite item

Full Text

Abstract

Introduction. Congenital malformations have long received the status of a marker of environmental distress. Six per cent of the newborns in the world are diagnosed with congenital malformations of various etiologies, 30 million develop intrauterine growth retardation, often associated with hypoxia, while the number of these pathologies is significantly higher in environmentally unfavourable regions.

The degree of resistance to hypoxia is determined by the transcription factor induced by hypoxic conditions — HIF. There is revealed polymorphism of the HIF gene, which determines the differences in the activity of the transcription factor encoded by this gene, and therefore, the differences in the level of resistance to hypoxia. Recently, HIF has also been detected in response to the activation of free radical processes.

Materials and methods. The study examined fifty five women living in the South of Kuzbass, most of them in the city of Novokuznetsk. 18 women were included in the control group because they carried a healthy child, the study group consisted of 11 women who gave birth to children with intrauterine growth retardation, and 26 women who gave birth to children with congenital malformations.

Genomic DNA was isolated from peripheral blood leukocytes using the phenol-chloroform extraction method. Gene typing was carried out by the Real Time method.

Results. Among the studied groups, in women who gave birth to children with congenital malformations, there were no reliable differences in the occurrence of polymorphisms of mutant and wild types. In the group of women who gave birth to children with intrauterine growth retardation, a reliable association of C/T polymorphism in the mother with intrauterine fetal growth retardation was shown (χ2 = 4.54; OR = 9.71), while the ancestral form of C/C was associated with resistance to this pathology.

Limitations. Since the identification of the association of the HIF-1А (rs11549465) gene polymorphism with intrauterine growth retardation was of a pilot nature, it is advisable to increase the sample.

Conclusion. The results obtained may indicate the leading role of the HIF-α subunit in the body’s adaptation to hypoxia and the secondary importance of this protein in the regulation of pro- and antioxidant balance.

Compliance with ethical standards. The examination of the patients complied with the ethical standards of the Bioethical Committee of the Research Institute for Complex Problems of Hygiene and Occupational Diseases, developed in accordance with the Helsinki Declaration of the World Association “Ethical Principles of Conducting Scientific Medical Research with Human Participation” as amended in 2013 and “Rules of Clinical Practice in the Russian Federation”, approved by the Order of the Ministry of Health of the Russian Federation No. 266 of June 19, 2003. All participants signed an informed consent to participate in the study.

Contribution:
Gulyaeva O.N. — concept and design of the study, collection and processing of material, statistical processing, editing;
Kazitskaya A.S. — collection and processing of material;
Zhukova A.G. — editing;
Zagorodnikova O.A. — collection and processing of material;
Alekseeva M.V. — collection and processing of material;
Renge L.V. — concept and design of the study.
All authors are responsible for the integrity of all parts of the manuscript and approval of the manuscript final version.

Conflict of interest. The authors declare no conflict of interest.

Acknowledgement. The study had no sponsorship.

Received: March 17, 2022 / Accepted: June 08, 2022 / Published: July 31, 2022

About the authors

Olga N. Gulyaeva

Research Institute for Complex Problems of Hygiene and Occupational Diseases

Author for correspondence.
Email: gulyaich1973@mail.ru
ORCID iD: 0000-0003-2225-6923

Senior researcher of the molecular-genetic and experimental study laboratory of the Research Institute for Complex Problems of Hygiene and Occupational Diseases, Novokuznetsk, 654041, Russian Federation.

e-mail: Gulyaich1973@mail.ru

Russian Federation

Anastasiya S. Kazitskaya

Research Institute for Complex Problems of Hygiene and Occupational Diseases

Email: noemail@neicon.ru
ORCID iD: 0000-0001-8292-4810
Russian Federation

Anna G. Zhukova

Research Institute for Complex Problems of Hygiene and Occupational Diseases

Email: noemail@neicon.ru
ORCID iD: 0000-0002-4797-7842
Russian Federation

Olga A. Zagorodnikova

Novokuznetsk City Clinical Hospital No. 1; Novokuznetsk State Institute for Further Training of Physicians - Branch Campus of the “Russian Medical Academy of Continuous Professional Education” of the Ministry of Healthcare of the Russian Federation

Email: noemail@neicon.ru
ORCID iD: 0000-0002-1075-2957
Russian Federation

Marina V. Alekseeva

Novokuznetsk City Clinical Hospital No. 1

Email: noemail@neicon.ru
ORCID iD: 0000-0001-7553-0856
Russian Federation

Lyudmila V. Renge

Novokuznetsk City Clinical Hospital No. 1; Novokuznetsk State Institute for Further Training of Physicians - Branch Campus of the “Russian Medical Academy of Continuous Professional Education” of the Ministry of Healthcare of the Russian Federation

Email: noemail@neicon.ru
ORCID iD: 0000-0002-7237-9721
Russian Federation

References

  1. Sharma D., Shastri S., Farahbakhsh N., Sharma P. Intrauterine growth restriction – part 1. J. Matern. Fetal. Neonatal. Med. 2016; 29(24): 3977–87. https://doi.org/10.3109/14767058.2016.1152249
  2. Nardozza L.M.M., Caetano A.C.R., Zamarian A.C.P., Mazzola J.B., Silva C.P., Marçal V.M.G., et al. Fetal growth restriction: current knowledge. Arch. Gynecol. Obstet. 2017; 295(5): 1061–77. https://doi.org/10.1007/s00404-017-4341-9
  3. Priante E., Verlato G., Giordano G., Stocchero M., Visentin S., Mardegan V., et al. Intrauterine Growth Restriction: New Insight from the Metabolomic Approach. Metabolites. 2019; 9(11): 267. https://doi.org/10.3390/metabo9110267
  4. Tang L., He G., Liu X., Xu W. Progress in the understanding of the etiology and predictability of fetal growth restriction. Reproduction. 2017; 153(6): 227–40. https://doi.org/10.1530/REP-16-0287
  5. Lafalla O., Esteban L.M., Lou A.C., Cornudella R., Domínguez M., Sanz G., et al. Clinical utility of thrombophilia, anticoagulant treatment, and maternal variables as predictors of placenta-mediated pregnancy complications: an extensive analysis. J. Matern. Fetal. Neonatal. Med. 2021; 34(4): 588–98. https://doi.org/10.1080/14767058.2019.1611764
  6. Silver R.M., Zhao Y., Spong C.Y., Sibai B., Wendel G. Jr., Wenstrom K. Prothrombin Gene G20210A Mutation and Obstetric Complications. Obstet. Gynecol. 2010; 115(1): 14–20. https://doi.org/10.1097/AOG.0b013e3181c88918
  7. Ganichkina M.B., Mantrova D.A., Kan N.E., Tyutyunnik V.L., Khachaturyan A.A., Ziganshina M.M. Pregnancy management complicated by intrauterine growth restriction. Akusherstvo i ginekologiya. 2017; (10): 5–11. https://doi.org/10.18565/aig.2017.10.5-11 (in Russian)
  8. Strizhakov A.N., Ignatko I.V., Timokhina E.V., Kardanova M.A. Critical Condition of the Fetus: Diagnostic Criteria, Obstetric Tactics, Perinatal Outcomes [Kriticheskoe sostoyanie ploda: diagnosticheskie kriterii, akusherskaya taktika, perinatal’nye iskhody]. Moscow: GEOTAR-Media; 2019. (in Russian)
  9. Peredvigina A.V. Frequency, Structure and Risk Factors for the Formation of Congenital Malformations of the Fetus and Newborn in the Udmurt Republic [Chastota, struktura i faktory riska formirovaniya vrozhdennykh porokov razvitiya ploda i novorozhdennogo v Udmurtskoy respublike]. Perm’; 2009. (in Russian)
  10. Towbin J.A., Casey B., Belmont J. The molecular basis of vascular disorders. Am. J. Hum. Genet. 1999; 64(3): 678–84. https://doi.org/10.1086/302303
  11. Woolf A.S., Winyard P.J.D. Molecular mechanisms of human embryogenesis: developmental pathogenesis of renal tract malformations. Pediatr. Dev. Pathol. 2002; 5(2): 108–29. https://doi.org/10.1007/s10024001-0141-z
  12. Durnev A.D. Prevention of induced mutagenesis. Meditsinskaya genetika. 2005; 4(4): 56. (in Russian)
  13. Gulyaeva O.N., Zhukova A.G., Kazitskaya A.S., Luzina F.A., Alekseeva M.V., Renge L.V., et al. The degree of anthropogenic load, gene polymorphism of the xenobiotic biotransformation system and congenital malformations as links in the same chain. Gigiena i Sanitaria (Hygiene and Sanitation, Russian journal). 2021; 100(7): 658–62. https://doi.org/10.47470/0016-9900-2021-100-7-658-662 (in Russian)
  14. Gulyaeva O.N., Kazitskaya A.S., Alekseeva M.V., Renge L.V., Zhukova A.G. The relationship between the frequency of congenital malformations in newborns of women residing in an industrial region with the polymorphism of the genes of the biotransformation system. Gigiena i Sanitaria (Hygiene and Sanitation, Russian journal) 2018; 97(7): 585–90. https://doi.org/10.18821/0016-9900-2018-97-7-585-590 (in Russian)
  15. Gordeeva L.A., Voronina E.N., Glushkov A.N. Genetic features of xenobiotics metabolism and susceptibility to pathology of pregnancy. Part I. Meditsina v Kuzbasse. 2016; 15(2): 8–16. (in Russian)
  16. Gulyaeva O.N., Kazitskaya A.S., Zagorodnikova O.A., Renge L.V., Zhukova A.G. Gene polymorphism of the xenobiotic biotransformation system and the intrauterine fetal growth retardation in female workers of industrial enterprises. Meditsina truda i promyshlennaya ekologiya. 2021; 61(6): 415–20. https://doi.org/10.31089/1026-9428-2021-61-6-415-420 (in Russian)
  17. Bogomolova T.Yu., Kalugina Z.I., Smirnova N.E., Soboleva S.V., Fadeeva O.P., Cherkashina T.Yu., et. al. Prospects and Risks of Human Potential Development in Siberia [Perspektivy i riski razvitiya chelovecheskogo potentsiala v Sibiri]. Novosibirsk; 2014. (in Russian)
  18. Sazontova T.G., Anchishkina N.A., Zhukova A.G., Bedareva I.V., Pilaeva E.A., Kriventsova N.A. The role of reactive oxygen species and redox signaling in adaptation to changes in oxygen levels. Fiziologichniy zhurnal. 2008; (2): 18–32. (in Russian)
  19. Pugh C.W., Ratcliffe P.J. New horizons in hypoxia signaling pathways. Exp. Cell Res. 2017; 356(2): 116–21. https:/doi.org/10.1016/j.yexcr.2017.03.008
  20. Alekhina D.A., Zhukova A.G., Sazontova T.G. Influence of small doses of inorganic fluoride compounds on the level of free radical oxidation and intracellular defense systems in the heart, lungs and liver. Tekhnologii zhivykh sistem. 2016; 13(6): 49–56. (in Russian)
  21. Zhukova A.G., Sazontova T.G. Hypoxia inducible factor-1α: function and biological role. Hypoxia Med. J. 2005; 13 (3–4): 34–41.
  22. Zakharenkov V.V., Mikhailova N.N., Zhdanova N.N., Gorokhova L.G., Zhukova A.G. Experimental study of the mechanisms of intracellular defense in cardiomyocytes associated with stages of anthracosilicosis development. Bull. Exp. Biol. Med. 2015; 159(4): 431–4. https://doi.org/10.1007/s10517-015-2983-9
  23. Ban J.J., Ruthenborg R.J., Cho K.W., Kim J.W. Regulation of obesity and insulin resistance by hypoxia-inducible factors. Hypoxia (Auckl.). 2014; 2: 171–83. https://doi.org/10.2147/HP.S68771
  24. Novikov V.E., Levchenkova O.S. Hypoxia-inducible factor as a pharmacological target. Obzory po klinicheskoy farmakologii i lekarstvennoy terapii. 2013; 11(2): 8–16. (in Russian)
  25. Formenti F., Constantin-Teodosiu D., Emmanuel Y., Cheeseman J., Dorrington K.L., Edwards L.M., et al. Regulation of human metabolism by hypoxia-inducible factor. Proc. Natl. Acad. Sci. USA. 2010; 107(28): 12722–7. https://doi.org/10.1073/pnas.1002339107
  26. Liu B., Liu Q., Song Y., Li X., Wang Y., Wan S., et al. Polymorphisms of HIF1A gene are associated with prognosis of early stage non-small-cell lung cancer patients after surgery. Med. Oncol. 2014; 31(4): 877. https://doi.org/10.1007/s12032-014-0877-8
  27. Guo X., Li D., Chen Y., An J., Wang K., Xu Zh., et al. SNP rs2057482 in HIF1A gene predicts clinical outcome of aggressive hepatocellular carcinoma patients after surgery. Sci. Rep. 2015; 5(1): 11846. https://doi.org/10.1038/srep11846
  28. Gladek I., Ferdin J., Horvat S., Calin G.A., Kunej T. HIF1A gene polymorphisms and human diseases: graphical review of 97 association studies. Genes Chromosomes Cancer. 2017; 56(6): 439–52. https://doi.org/10.1002/gcc.22449
  29. Zhukova A.G., Kazitskaya A.S., Sazontova T.G., Mikhaylova N.N. Hypoxia-inducible factor (hif): structure, function and genetic polymorphism. Gigiena i Sanitaria (Hygiene and Sanitation, Russian journal). 2019; 98(7): 723–28. https://doi.org/10.18821/0016-9900-2019-98-7-723-728 (in Russian)
  30. Schmidt R.J., Romitti P.A., Burns T.L., Murray J.C., Browne M.L., Druschel C.M., et al. Caffeine, selected metabolic gene variants, and risk for neural tube defects. Birth Defects Res. A. Clin. Mol. Teratol. 2010; 88(7): 560–9. https://doi.org/10.1002/bdra.20681
  31. Spitsyn V.A. Biochemical Polymorphism of Man: Anthropological Aspects [Biokhimicheskiy polimorfizm cheloveka: antropologicheskie aspekty]. Moscow; 1985. (in Russian)
  32. Artamonova V.G. Actual problems of industrial ecology and prevention of occupational diseases. Vestnik Rossiyskoy akademii meditsinskikh nauk. 1998; (1): 38–42. (in Russian)
  33. Akhmetov I.I., Khakimullina A.M., Lyubaeva E.V., Vinogradova O.L., Rogozkin V.A. Effect of HIF1A gene polymorphism on human muscle performance. Byulleten’ eksperimental’noy biologii i meditsiny. 2008; 146(9): 327–9. (in Russian)
  34. Zhur K.V., Kundas L.A., Byshnev N.I., Morozik P.M., Mosse I.B. HIF1A gene as a genetic marker of athlete’s resistance to exercises. Vestnik Bashkirskogo gosudarstvennogo agrarnogo universiteta. 2013; (3): 58–60. (in Russian)
  35. McPhee J.S., Perez-Schindler J., Degenes H., Tomlinson D., Hennis P., Baar K., et al. HIF1A P582S gene association with endurance training responses in young women. Eur. J. Appl. Physiol. 2011; 111(9): 2339–47. https://doi.org/10.1007/s00421-011-1869-4
  36. Semenza G.L. Signal transduction to hypoxia-inducible factor 1. Biochem. Pharmacol. 2002; 64(5-6): 993–8. https://doi.org/10.1016/s0006-2952(02)01168-1

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2024 Gulyaeva O.N., Kazitskaya A.S., Zhukova A.G., Zagorodnikova O.A., Alekseeva M.V., Renge L.V.



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 37884 от 02.10.2009.